Drugs affecting ‘clock’ genes could help tackle diabetes and obesity
Two synthetic molecules were used to alter the activity of “clock” genes that control night-and-day based body functions.
Most living things, including humans, possess circadian rhythms that respond to 24-hour cycles of light and dark.



